Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach

Hochepied, 2003, C. Libert, Cytokine Growth Factor Rev., 14, 25, 10.1016/S1359-6101(02)00054-0 Piafsky, 1978, N. Engl. J. Med., 299, 1435, 10.1056/NEJM197812282992604 Schonfeld, 2008, J. Mol. Biol., 384, 393, 10.1016/j.jmb.2008.09.020 Fournier, 2000, Biochim. Biophys. Acta Protein Struct. Mol. Enzymol., 1482, 157, 10.1016/S0167-4838(00)00153-9 Haston, 2002, Biomed. Chromatogr., 16, 332, 10.1002/bmc.162 Chuang, 2005, Biochim. Biophys. Acta Gen. Subj., 1725, 385, 10.1016/j.bbagen.2005.05.021 Fitos, 2010, Biochim. Biophys. Acta Gen. Subj., 1800, 367, 10.1016/j.bbagen.2009.08.006 De Ceukeleire, 2002, Carbohydr. Res., 337, 1405, 10.1016/S0008-6215(02)00165-9 Maruyama, 1990, Chem. Pharm. Bull., 38, 1688, 10.1248/cpb.38.1688 Kim, 2006, Clin. Chim. Acta, 369, 46, 10.1016/j.cca.2006.01.002 Atreya, 2013, Cancer Res., 73, 10.1158/1538-7445.AM2013-1201 Aftab, 2012, Mechanistic Studies of Cabozantinib, A Met-VEGFR2 Inhibitor With Anti-Tumor Activity In Soft Tissue And Bone, 20 Viola, 2013, Future Oncol., 9, 1083, 10.2217/fon.13.128 Vaishampayan, 2013, Curr. Oncol. Rep., 15, 76, 10.1007/s11912-012-0289-x van Vollenhoven, 2012, N. Engl. J. Med., 367, 508, 10.1056/NEJMoa1112072 U.S. Food and Drug Administration (FDA), 2012, Tofacitinib Maeshima, 2012, Arthritis Rheum., 64, 1790, 10.1002/art.34329 Sandborn, 2012, N. Engl. J. Med., 367, 616, 10.1056/NEJMoa1112168 Papp, 2012, Br. J. Dermatol., 167, 668, 10.1111/j.1365-2133.2012.11168.x Garabagiu, 2011, Mater. Res. Bull., 46, 2474, 10.1016/j.materresbull.2011.08.032 Tunc, 2014, J. Lumin., 151, 22, 10.1016/j.jlumin.2014.02.004 Tunc, 2013, J. Photochem. Photobiol. B Biol., 120, 59, 10.1016/j.jphotobiol.2013.01.011 Tunc, 2013, J. Lumin., 140, 87, 10.1016/j.jlumin.2013.03.015 Duman, 2013, B.K. Bozoglan, J. Fluoresc., 23, 659, 10.1007/s10895-013-1177-y Zhang, 2012, Y. Liu, J. Solut. Chem., 41, 422, 10.1007/s10953-012-9809-4 Tunc, 2014, B.K. Bozoglan, J. Hazard. Mater., 273, 36 Tanaka, 1995, J. Macromol. Sci., Part A: Pure Appl. Chem., 32, 339, 10.1080/10601329508011166 Ayranci, 2004, O. Duman, Food Chem., 84, 539, 10.1016/S0308-8146(03)00276-0 Ayranci, 2004, O. Duman, Protein Pept. Lett., 11, 331, 10.2174/0929866043406814 Bozoglan, 2014, J. Lumin., 155, 198, 10.1016/j.jlumin.2014.06.032 Zsila, 2007, Biochim. Biophys. Acta Gen. Subj., 1770, 797, 10.1016/j.bbagen.2007.01.009 Zaidi, 2013, J. Phys. Chem. B, 117, 2595, 10.1021/jp3069877 Albani, 2003, Carbohydr. Res., 338, 1097, 10.1016/S0008-6215(03)00075-2 Alam, 2015, J. Lumin., 164, 123, 10.1016/j.jlumin.2015.03.011 Chaturvedi, 2015, Mol. BioSyst., 11, 307, 10.1039/C4MB00548A Shaw, 2008, J. Photochem. Photobiol. B Biol., 90, 187, 10.1016/j.jphotobiol.2008.01.001 Zhang, 2007, J. Photochem. Photobiol. B Biol., 86, 246, 10.1016/j.jphotobiol.2006.11.002 Ajmal, 2015, J. Biomol. Struct. Dyn., 1 Cordero, 2008, Tuberculosis, 88, 203, 10.1016/j.tube.2007.10.004 Alam, 2014, Cell Biochem. Biophys., 71, 1199, 10.1007/s12013-014-0329-2 Vetri, 2011, Arch. Biochem. Biophys., 508, 13, 10.1016/j.abb.2011.01.024 Khan, 2014, Int. J. Biol. Macromol., 70, 606, 10.1016/j.ijbiomac.2014.07.027 Chaturvedi, 2015, PLoS One, 10 Khan, 2015, Int. J. Biol. Macromol., 78, 417, 10.1016/j.ijbiomac.2015.04.021 Otagiri, 2005, Drug Metab. Pharmacokinet., 20, 309, 10.2133/dmpk.20.309 P. Alam, S.K. Chaturvedi, T. Anwar, M.K. Siddiqi, M.R. Ajmal, G. Badr, M.H. Mahmoud, R.H. Khan, J. Lumin. 164 123–130. Wang, 2014, Anal. Chem., 86, 10186, 10.1021/ac502440h Zaman, 2014, Int. J. Nanomedicine, 9, 899 Østergaard, 2009, Anal. Chem., 81, 8644, 10.1021/ac901419x Ahmad, 2012, PLoS One, 7 Zaidi, 2013, PLoS One, 8 Huang, 2012, J. Mol. Recognit., 25, 642, 10.1002/jmr.2221